Chembiochem by Sato, Michio et al.
Involvement of Lipocalin-like CghA in Decalin-Forming 
Stereoselective Intramolecular [4+2] Cycloaddition
Dr. Michio Sato[a], Dr. Fumitoshi Yagishita[b], Prof. Dr. Takashi Mino[b], Dr. Nahoko 
Uchiyama[c], Dr. Ashay Patel[d], Dr. Yit-Heng Chooi[e], Dr. Yukihiro Goda[c], Dr. Wei Xu[e], 
Prof. Dr. Hiroshi Noguchi[a], Tsuyoshi Yamamoto[a], Prof. Dr. Kinya Hotta[f], Prof. Dr. Kendall 
N. Houk[d], Prof. Dr. Yi Tang[e], and Prof. Dr. Kenji Watanabe[a]
Kenji Watanabe: kenji55@u-shizuoka-ken.ac.jp
[a]Department of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526 (Japan)
[b]Department of Applied Chemistry and Biotechnology, Graduate School of Engineering, Chiba 
University, Chiba 263-8522 (Japan)
[c]National Institute of Health Sciences, Tokyo 158-8501 (Japan)
[d]Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095 
(USA)
[e]Department of Chemical and Biomolecular Engineering and Department of Chemistry and 
Biochemistry, University of California, Los Angeles, CA 90095 (USA)
[f]School of Biosciences, The University of Nottingham Malaysia Campus, Selangor 43500 
(Malaysia)
Abstract
Understanding enzymatic Diels—Alder (DA) reactions that can form complex natural product 
scaffold is of considerable interest. Sch 210972 1, a potential anti-HIV fungal natural product, 
contains a decalin core that is proposed to form via a DA reaction. We identified the gene cluster 
responsible for the biosynthesis of 1 and heterologously reconstituted the biosynthetic pathway in 
Aspergillus nidulans to characterize the enzymes involved. Most notably, deletion of cghA 
resulted in a loss of stereoselective decalin core formation, yielding both an endo 1 and a 
diastereomeric exo adducts of the proposed DA reaction. Complementation with cghA restored the 
sole formation of 1. Density functional theory computation of the proposed DA reaction provided 
a plausible explanation of the observed pattern of product formation. Based on our study, we 
propose that lipocalin-like CghA is responsible for the stereoselective intramolecular [4+2] 
cycloaddition that forms the decalin core of 1.
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While Diels—Alder (DA) reaction, including catalytic variants of the reaction, has seen 
great use in chemical synthesis, the biogenic and biocatalytic DA reactions are less well 
characterized. However, designed proteins[1] and nucleic acids[2] are capable of catalyzing 
the DA reaction, suggesting that biomolecules can act as competent catalysts for the 
cycloaddition. The DA reaction has been established as a key transformation in biosynthesis 
of a growing number of natural products.[3] Despite these proposals, the identification of 
enzymes, Diels–Alderases (DAases), that catalyze the cycloaddition has proven challenging. 
In fact, only a handful of DAases have been identified based upon biochemical and structural 
studies, including lovastatin nonaketide synthase (LovB),[4] solanapyrone synthase,[5] SpnF 
involved in the biosynthesis of spinosyn A[6] and most recently VstJ from the versipelostatin 
biosynthetic pathway responsible for the formation of spirotetronate framework.[7] Of these 
examples, SpnF and VstJ are the only enzymes for which specific rate accelerations of [4+2] 
cycloaddition reactions have been verified experimentally. Given the limited understanding 
of the enzymatic DA reactions and the potential synthetic utility of (re)engineered DAases, 
additional studies establishing the existence and the catalytic modes of natural DAases are 
warranted.
We have investigated the biosynthetic pathway responsible for the formation of the tetramic 
acid-containing metabolite Sch 210972 1 (Figure 1) from Chaetomium globosum. This 
compound exhibits unique inhibitory activity against CCR-5, a cell surface receptor that 
allows the entry of HIV-1 into cells, and is an attractive lead compound for novel anti-HIV 
therapeutics.[8] Previous studies have shown that the tetramic acid moieties in related 
compounds, such as equisetin 2[9] (Scheme 1) and cyclopiazonic acid[10], are formed via a 
Dieckmann-type condensation that is catalyzed by reductive domains located at the C-
termini of polyketide synthase nonribosomal peptide synthetase hybrid megaenzymes (PKS–
NRPSs)[11]. Thus, we hypothesized that the framework of 1 was also biosynthesized by a 
hybrid PKS–NRPS. The structural similarity of 1, 2 and lovastatin 3 suggested that the 
decalin core of 1 may be formed by an intramolecular DA reaction, as proposed for the 
biocatalytic formation of the decalin cores of 2 and 3 (Figure 1B).[12] To gain further insight 
into the mechanism of biosynthesis of 1 and to determine if a DA reaction is indeed involved 
in the biosynthesis of 1, we identified the C. globosum gene cluster responsible for the 
biosynthesis of 1 for a detailed investigation.
A BLASTP[13] search of the genome of C. globosum identified three recognizable hybrid 
PKS–NRPS genes: CHGG_01239, CHGG_05286 and CHGG_02374–CHGG_02378. We 
have recently reported that CHGG_01239 codes for the PKS–NRPS CheA responsible for 
the formation of chaetoglobosin-type of natural products[14] (Figure S13), and deletion of 
CHGG_05286 did not affect the production of 1. Therefore, the reassigned ORF 
CHGG_02374–CHGG_02378, which we have named cghG, was predicted and later 
confirmed to code for the PKS–NRPS responsible for the biosynthesis of 1 (Supporting 
Methods; Table S2; Figures S1–S9; S14, i vs. viii). The chemical structure of 1 was 
characterized using high-resolution (HR) electrospray ionization (ESI) LCMS, 1H NMR 
and 13C NMR. (Table S3 and Figure S16, S17), and the absolute configuration of 1 was 
determined crystallographically (Figure S18 and Tables S5–S12). Additionally, this class of 
PKS NRPS is often accompanied by a stand-alone enoyl reductase (ER) that works in trans 
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with the PKS NRPS for reduction of polyketide backbone double bonds that is required for 
the formation of the final products.[11, 15] Based on homology to CheB, the ER involved in 
chaetoglobosin biosynthesis,[16] CghC was predicted to be the stand-alone ER for the 
biosynthesis of 1 (Table S2), and its disruption abolished the production of 1 (Figure S14, i 
vs. iv). Lastly, disruption of cghD also showed a complete loss of production of 1 (Figure 
S14, i vs. v), presumably because CghD is the GAL4-type transcription factor that activates 
the expression of the cgh genes.
One unique structural feature of 1 is the tetramic acid motif proposed to be derived from a 
non-proteinogenic amino acid, γ-hydroxymethyl-L-glutamic acid 5 via a Dieckmann-type 
condensation catalyzed by the reductase domain of CghG (Figure 1B) like in the case of the 
biosynthesis of 2.[17] Because the cgh gene cluster possessed an aldolase-coding cghB, we 
proposed CghB to catalyze the aldol condensation of two molecules of pyruvic acid to yield 
the intermediate 4, which can then be stereoselectively transaminated to form 5 (Figure 1A). 
To test this hypothesis, we prepared 5 and its diastereomers chemoenzymatically[18] and 
used them in feeding experiments with an engineered C. globosum strain, CGKW14[19] 
(Supporting Methods). After confirming the loss of production of 1 by ΔcghB/CGKW14 
(Figure S14 i vs. iii), we fed 5 to this strain to observe the recovery of the production of 1 
(Figure 2). Amination of 4 is likely performed by a transaminase in the cell. On the other 
hand, feeding of a diastereomer of 5, (2S,4R)-4-hydroxy-4-methylglutamic acid 6 
(Supporting Methods) failed to restore the production of 1 in ΔcghB/CGKW14 (Figure S15). 
These results suggest that CghB is responsible for supplying 5 to CghG to complete the 
biosynthesis of 1, and also revealed the stereospecificity of the adenylation domain of the 
NRPS segment of CghG.
The biosynthetic gene clusters for all of the compounds except 3 in Scheme 1 contain a gene 
encoding hypothetical proteins that are homologous to one another (Figure S13). For 1, this 
gene corresponds to cghA (Table S2). While CcsF, the homolog of CghA in the cytochalasin 
E biosynthetic pathway, was suggested to play a possible role in the formation of the 
isoindolone core by catalyzing a DA reaction, none of those cghA-like genes has been 
examined experimentally until now. When cghA was disrupted, 1 was still formed, albeit in 
a reduced quantity (Figure S14, i vs. ii) but also resulted in the formation of a second 
compound, 7 (Figure 3, ii). The wild type CGKW14 strain did not form 7 (Figure 3, i). 
Detailed characterizations by HR-ESI-LCMS, 1H NMR and 13C NMR (Table S4 and Figure 
S19–S24) and X-ray crystallography (Figure S18), 7 was determined to be a diastereomer of 
1 where 1 and 7 correspond to the endo and exo adduct of the proposed decalin-forming 
[4+2] cycloaddition reaction, respectively. The transition states leading to these cycloadducts 
are shown in Scheme 2.
To confirm the involvement of CghA in dictating the course of the stereoselective 
intramolecular [4+2] cycloaddition reaction, we conducted a complementation experiment in 
which a functional copy of the cghA gene was reintroduced to the ΔcghA/CGKW14 strain. 
We chose to integrate cghA into the chaetoviridin biosynthetic PKS gene cazM[20] so that 
the integration event would be indicated by the loss of formation of chaetoviridin A 8 and B 
9.[19] A control experiment verified that disruption of cazM would not affect the production 
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of 1 (Figure 4, i vs. ii). Comparison of the extract from the cghA-knockout strain and the 
cghA-complemented strain showed that the biosynthesis of 7 was no longer observed and 
exclusive production of 1 was restored with cghA (Figure 4, iii vs. iv), indicating CghA is 
directly responsible for ensuring the stereoselective formation of 1 and suppressing the 
nonenzymatic formation of the alternative stereoisomer, 7. Furthermore, the Sch 210972 
biosynthetic pathway was reconstituted in a heterologous host to eliminate any interfering 
effects in C. globosum that can obscure our findings (see SI for details). As expected, 
introduction of cghA, cghB, cghC and cghG to Aspergillus nidulans A1145 resulted in the 
formation of 1 (Figure 5 i vs. ii), while exclusion of cghA led to the formation of 1 and 7 
(Figure 5 iii). These results clearly indicate that CghA selectively promotes a single 
stereochemical pathway among the decalin-forming intramolecular [4+2] cycloaddition 
reaction pathways to yield 1 exclusively.
Lastly, to quantitate the stereoselectivity of the cycloaddition, we computed the DA reaction 
of model substrates 10 and 11 shown in Figure 6A and S25 using the M06-2X density 
functional and 6-31+G(d,p) basis with the SMD implicit solvation model. Computations of 
the reaction with both substrates led to similar conclusions. Therefore, the discussion here 
will focus on the computations of the DA reaction of a truncated substrate 10. Details 
regarding density functional theory computations of the cycloaddition of 10 and 11 and our 
computational methods are presented in the Supporting Methods. The activation free 
energies and the transition structures for the formation of the four stereoisomeric 
cycloadduct of 10 are shown in Figure 6B. The barriers for the formation of these 
stereoadducts ranged from 18 to 27 kcal/mol. TS10endo1 and TS10exo1, the lowest energy 
transition structures, led to cycloadducts 12a and 12b, which are analogous in terms of 
stereochemistry to the adducts 1 and 7 formed by the cghA strain. The dominant adduct 
formed in the ΔcghA strain was 1 with 7 being a less prevalent product (Figure 3 ii), and our 
computations reproduced this selectivity trend correctly. The transition state for the 
formation of 12a (TS10endo1) is 1.3 kcal/mol lower in energy than the transition state 
leading to 12b (TS10exo1), suggesting approximately a 10:1 preference for the formation of 
12a. TS10exo1 is destabilized by a 1,3-diaxial interaction involving the methylene group of 
the diene. Similar, but more severe 1,3-diaxial interactions destabilize the other endo and 
exo transition states (TS10exo2 and TS10endo2), causing them to be more than 4 kcal/mol 
higher in energy than TS10endo1.
Sequence analysis of CghA and its homologs by FFAS03[21] identified a calycin-like β-
barrel protein NE1406[22] as the closest structural homolog of CghA. Another family of 
calycin-like β-barrel proteins called dirigent proteins is known to sequester and orient 
phenoxy radicals to direct stereospecific formation of dilignols, precursors to lignin and 
lignans.[23] In a similar fashion, CghA-like proteins may also bind specific conformations of 
their straight-chain polyketide substrates to promote the [4+2] cycloaddition reaction and to 
control the stereoselectivity of the reaction. Computations indicate that catalysis by substrate 
preorganization could accelerate the cycloaddition by as much a 1,000-fold at 30 °C, as the 
reactive conformer for the formation of 12a is 4 kcal/mol higher in energy than the global 
minimum conformer. Hydrogen bonding of the enone carbonyl in the active site of CghA 
could also activate the precursor and further accelerate the cycloaddition. While detailed in 
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vitro characterization of the biosynthesis of 3[4] and the recent identification of SpnF[6] and 
VstJ[7] indicate strongly the existence of natural enzymes that catalyze DA reactions, little 
remains known about how exactly these enzymes catalyze asymmetric DA reactions. Efforts 
to further study the CghA-catalyzed intramolecular [4+2] cycloaddition reaction are 
currently underway to understand the possible involvement of DA-catalyzing enzymes in 
natural product biosynthesis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Proposed biosynthetic pathway of 1. (A) Formation of an unusual amino acid, γ-
hydroxymethyl-L-glutamic acid 5, from two molecules of pyruvic acid dimerized by an 
aldolase CghB. (B) CghG-catalyzed synthesis of the linear substrate and a tetramic acid 
moiety, and the two final products that can be formed by the proposed Diels–Alder reaction. 
Abbreviations: KS, ketosynthase; MAT, malonyl-CoA acyltransferase; DH, dehydratase; 
MT, methyltransferase; KR, ketoreductase; ACP, acyl carrier protein; C, condensation; A, 
adenylation; T, thiolation; R, reductase; ER, enoyl reductase; SAM, S-adenosyl-L-
methionine.
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Confirmation of the activity of CghB by bioconversion of synthetic substrate 5 to 1 in C. 
globosum. HPLC traces of extracts of the culture of (i) wild-type control CGKW14, (ii) 
negative control of ΔcghB/CGKW14 without fed 5 and (iii) ΔcghB/CGKW14 with fed 5.
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HPLC analysis of the metabolites from cghA strain of C. globosum. HPLC traces of extracts 
of the culture of (i) wild-type control CGKW14 and (ii) deletion mutant ΔcghA/CGKW14. 
The yield of 1 and 7 from the ΔcghA/CGKW14 culture were 2 and 1 mg/L, respectively, 
whereas 60 mg/L of 1 was isolated from the wild-type reference CGKW14 culture.
Sato et al. Page 9














Confirmation of the role of CghA in the selective formation of 1 by complementing the 
cghA-disruption mutant with cghA in C. globosum. HPLC traces of extracts of the culture of 
(i) wild-type control CGKW14, (ii) ΔcazM/CGKW14 as a control showing the loss of 
production of 8 and 9, (iii) ΔcghA/ ΔcazM/CGKW14 and (iv) ΔcghA/cazM∷cghA/
CGKW14. Authentic reference of (v) 1 and (vi) 7.
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Reconstitution of the biosynthesis of 1 in Aspergillus nidulans A1145 and loss of 
stereoselective product formation upon elimination of cghA. HPLC traces of metabolic 
extracts from the culture of (i) wild-type A. nidulans A1145 control, (ii) A. nidulans 
harboring cghA, cghB, cghC and cghG and (iii) A. nidulans harboring cghB, cghC and 
cghG. Authentic reference of (iv) 1 and (v) 7.
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Computational studies of the proposed Diels–Alder reaction involved in the biosynthesis of 
Sch 210972. (A) Truncated substrates examined using density functional theory. (B) 
Computed transition structures of the intramolecular Diels–Alder reaction of 10. The 
activation free energy (bold) and th e forming bond lengths are given. Unfavorable 1,3-
diaxial interactions are indicated by opposing arcs.
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Natural products putatively biosynthesized via Diels–Alder reactions. Resulting cyclohexyl 
groups are shown in gray.
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The endo and exo transition state of the [4+2] cycloaddition, leading to the formation of 1 
and 7, respectively.
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